An In Vitro Examination of Whether Kratom Extracts Enhance the Cytotoxicity of Low-Dose Doxorubicin against A549 Human Lung Cancer Cells

Doxorubicin is an effective chemotherapeutic agent in the treatment of solid hematological and non-hematological carcinoma. However, its long-term usage could result in side effects, such as cardiomyopathy, chronic heart failure, neurotoxicity and cancer cell resistance. In this study, we reported t...

Full description

Bibliographic Details

Published in:	Molecules
Main Authors:	Asep Bayu, Siti Irma Rahmawati, Firmansyah Karim, Jonathan Ardhianto Panggabean, Dasilva Primarindu Nuswantari, Dwi Wahyu Indriani, Peni Ahmadi, Rendi Witular, Ni Luh Putu Indi Dharmayanti, Masteria Yunovilsa Putra
Format:	Article
Language:	English
Published:	MDPI AG 2024-03-01
Subjects:	kratom <i>Mitragyna speciosa</i> alkaloid mitragynine cytotoxicity anticancer
Online Access:	https://www.mdpi.com/1420-3049/29/6/1404